Why the Imricor (ASX:IMR) share price is edging higher today

The Imricor Medical Systems Inc. (ASX: IMR) share price is edging higher today following two major announcements.

| More on:
medical asx share price represented by doctor giving thumbs up

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Imricor Medical Systems Inc. (ASX: IMR) share price is edging higher today following two major announcements. During later afternoon trade, the medical device company's shares are marginally up 0.44% to $2.30.

Clinical sites update

In the first announcement, Imricor provided an update in regards to the signing of new agreements with European clinical sites.

Management said that having faced severe disruptions from the second wave of COVID-19, its sales process has been delayed. Originally, the company planned to have 14 clinical sites with agreements to purchase Imricor's products at the end of 2020. However, with the emergence of significant COVID-19 cases on the rise, the company revised its forecast for the new year.

Imricor now anticipates it will have sales agreements with 9 clinical sites in early 2021. Furthermore, the company is projecting a strong short-term sales pipeline.

What did the head of Imricor say?

Commenting on the challenges, Imricor chair and CEO Mr Steve Wedan said:

November and December were extremely difficult in Europe particularly for targeted clinical sites in Germany and The Netherlands where further COVID-19 containment measures were implemented during this period.

… We have continued to make excellent progress with many of these sites, with agreements advanced to the stage of final review and execution. We therefore expect these delays to be minor and continue to schedule and plan installation and training with our new sites accordingly.

Looking beyond our commercialisation plans in Europe, our product development is on track, our geographical expansion into the US and Australian markets are progressing as planned and clinical trials for expanding our product indications are moving forward on schedule.

New COO appointment

Further to the announcement, management advised it has created a new role of chief operating officer (COO). Effective 1 January 2021, Mr Gregg Stenzel will take up the COO appointment, which was created to enable the group to focus on achieving its strategic objectives.

Mr Stenzel previously held the position of vice president of operations in Imricor. His duties included overseeing the company's operations and development of manufacturing strategies.

Chair and CEO, Mr Wedan, commented:

The Board and I are thrilled to appoint Gregg to this important role along with the opportunity it provides to increase my focus on our sales and marketing efforts as we approach an exciting year ahead for Imricor and the acceleration of the commercialisation phase of our growth strategy.

About the Imricor share price

The Imricor share price has performed well over the course of the year, jumping above 90%. Although its shares tumbled to an all-time low of 75 cents in March, shareholders who bought then would be sitting on gains of 206%.

It's worth noting that the company's shares recently hit an all-time high of $2.94 in late October.

Based on current share price levels, the company commands a market capitalisation of around $288 million.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the 'five best ASX stocks' for investors to buy right now. We believe these stocks are trading at attractive prices and Scott thinks they could be great buys right now...

See The 5 Stocks *Returns as of 30 April 2025

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

A smiling woman at a hardware shop selects paint colours from a wall display.
Broker Notes

After its strategy day, what does Macquarie think Wesfarmers shares are worth?

Let's see what the broker is saying about this blue chip.

Read more »

Buy, hold, and sell ratings written on signs on a wooden pole.
Technology Shares

After surging 13% yesterday, are TechnologyOne shares a buy, hold or sell according to Macquarie?

Valuations matter when investing, and Macquarie feels no different.

Read more »

A woman presenting company news to investors looks back at the camera and smiles.
Broker Notes

Broker reveals which ASX stocks are rate-cut winners

Macquarie is tipping three further interest rate cuts in July, August, and November.

Read more »

Ecstatic woman looking at her phone outside with her fist pumped.
Broker Notes

Where to invest $1,000 into ASX 200 shares in June

Goldman Sachs is tipping these shares as buys. Let's find out why.

Read more »

A happy male investor turns around on his chair to look at a friend while a laptop runs on his desk showing share price movements
Share Market News

5 things to watch on the ASX 200 on Friday

A better session is expected for Aussie investors today.

Read more »

A man looking at his laptop and thinking.
Share Gainers

Here are the top 10 ASX 200 shares today

The markets lost their steam this Thursday.

Read more »

A young man pointing up looking amazed, indicating a surging share price movement for an ASX company
Broker Notes

3 amazing ASX 200 shares to buy and hold forever

Brokers think these shares are in the buy zone. Let's see why they could be top buy and hold picks.

Read more »

iPhone with the logo and the word Google spelt multiple times in the background.
Opinions

I've been buying these 2 US stocks in 2025. Here's why

Sometimes the US markets are a better place to go shopping for stocks.

Read more »